September 16, 2011
MEDICAL UNIVERSITY of SOUTH CAROLINA
Vol. 30, No. 5
Research hits national news Clinical trial makes surprising find about best treatment for stroke
Dr. Marc Chimowitz views a brain scan of one of his patients.
How the study defines aggressive medical management q a daily dosage of 325 milligrams of aspirin; q 75 milligrams a day of clopidogrel, a medication used to prevent blood clots, for 90 days after enrollment; q and intensive management of key
3
stroke risk factors — high blood pressure and high levels of low density lipoprotein (LDL), the unhealthy form of cholesterol. All patients also participated in a lifestyle modification program which focused on quitting smoking, increasing
SeaSonS Program Older patients with psychiatric issues benefit from alternative treatment.
10
exercise, weight loss in overweight patients, healthy diet and controlling risk factors such as diabetes, high blood pressure and cholesterol. For more data and study details, visit the New England Journal of Medicine’s website: http://tinyurl.com/44yhttn.
Some things never get old – such as being published in the New England Journal of Medicine with results from a 50-center nationwide clinical trial that changes the standard of care for stroke patients worldwide. Lead investigator Marc Chimowitz, MBChB, a neurosciences professor and SmartState endowed chair, said he’s been surprised but gratified at the extent of national coverage of the research study that has landed headlines in newspapers from The New York Times to The Washington Post. “Large clinical trials are my passion because they have the potential to impact not just the care of the people you take care of one-on-one but potentially patients worldwide.” The new study reveals that aggressive medical therapy is safer and more effective than placing a stent in the brain to ward off a second stroke in high-risk patients with a narrowed brain artery. Investigators published the results from the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (Sammpris) trial on Sept. 7 online in the New England Journal of Medicine. “There were two surprising findings
See Research on page 8
ParkinSon’S DiSeaSe
2
Around Campus
MUSC’s Movement Disorders Program launches study aimed at repairing the brain.
5
Meet Vivian
11
Classifieds
READ THE CATALYST ONLINE - http://www.musc.edu/catalyst